UnknownPhase 4

Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects

Finland30 participants

Plain-language summary

The study will find out how effective rupatadine is in the treatment of mosquito bite symptoms in adult patients allergic to mosquito bites.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Recent history of suffering from mosquito-bite reactions. * At least 5 mm diameter mosquito-bite wheal from Aedes aegypti laboratory mosquitoes Exclusion Criteria: * Pregnancy or lactating females * Oral antihistamines, corticosteroids or non-steroid anti-inflammatory drugs (NSAID) use within two weeks before the study. * Severe or moderate systemic illness * Allergy to rupatadine or other antihistamines * Anaphylaxis from mosquito bites

What they're measuring

Bite lesion size (squared mm)

Trial details

NCT IDNCT00258141

SponsorJ. Uriach and Company

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Contact for this trial

Timo Reunala, Prof.

(+358) 331165167 timo.reunala@uta.fi

View on ClinicalTrials.gov More Allergy trials